País: Irlanda
Idioma: anglès
Font: HPRA (Health Products Regulatory Authority)
IBUPROFEN
Crookes Healthcare Ltd
IBUPROFEN
400 Milligram
Unknown
Withdrawn
2007-08-15
PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Nurofen Micro-Granules 400 mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Ibuprofen Ph. Eur. 400mg. 3 PHARMACEUTICAL FORM Effervescent granules 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS As an anti-inflammatory and analgesic in the short term relief of muscular strain, backache, period pain and dental pain. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral administration. Adults and children over 12 years: Initial dose contents of one sachet. Place contents of one sachet in a glass and half fill with water and stir. Drink immediately. Then, if necessary, one sachet every 4 hours. Do not take more than 3 sachets in 24 hours. Not suitable for children under 12 years of age. Elderly: see statements in Section 4.4. 4.3 CONTRAINDICATIONS Patients with existing, or a history of peptic ulceration, or other gastrointestinal disorders. Hypersensitivity to any of the constituents, aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs). Patients with a history of bronchospasm, rhinitis, urticaria associated with aspirin or other NSAID. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE If symptoms persist for more than 3 days or any other symptoms not related to original condition, are experienced, the treatment should be discontinued immediately and a doctor should be consulted. Undesirable effects may be reduced by using the minimum effective dose for the shortest possible duration. Caution is required in patients with renal, cardiac or hepatic impairment. In patients with renal impairment, renal function should be monitored since it may deteriorate following the use of any NSAID. IRISH MEDICINES BOARD _____________________________________________________________________________________________________________________ Llegiu el document complet